ENT-23

N/A

Report date: 2026/02/14 20:00:22
NME

Base Information

Drug NameENT-23
Drug Alias NameENT-23ENT23
ClassificationSmall molecules
Mechanisms of ActionProtein-tyrosine phosphatase 1B modulators
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetabolics Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetabolics Pharma Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A